Standard Biotools reported $-7.83M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 83.5M 13.9M Sep/2026
Danaher USD 1.25B 118M Sep/2026
Illumina USD 305M 45M Sep/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Nikon Corporation JPY 9.9B 10.9B Sep/2026
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Revvity USD 124.63M 1.51M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sony JPY 645.12B 170.62B Sep/2026
Standard Biotools USD -7.83M 1.59M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Waters USD -86M 234M Jun/2026